Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation

References

• MichorFIwasaYLengauerCNowakMADynamics of colorectal cancerSemin Cancer Biol200515648449316055342
   PubMed Web of Science ®Google Scholar
• NishiyamaNKataokaKCurrent state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene deliveryPharmacol Ther2006112363064816815554
   PubMed Web of Science ®Google Scholar
• TorchilinVPTargeted pharmaceutical nanocarriers for cancer therapy and imagingAAPS J200792E12814717614355
   PubMed Web of Science ®Google Scholar
• JunYJKimJIJunMJSohnYSSelective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugatesJ Inorg Biochem20059981593160115963570
   PubMed Web of Science ®Google Scholar
• GreishKEnhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicinesJ Drug Target20071578457464
   Web of Science ®Google Scholar
• IyerAKKhaledGFangJMaedaHExploiting the enhanced permeability and retention effect for tumor targetingDrug Discov Today2006111718812818
   Web of Science ®Google Scholar
• WangCPhamPTPolymers for viral gene deliveryExpert Opin Drug Deliv20085438540118426381
   PubMed Web of Science ®Google Scholar
• LingYYangYLuNEndostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cellsBiochem Biophys Res Commun20073611798417644065
   PubMed Web of Science ®Google Scholar
• ZhuoWLuoCWangXSongXFuYLuoYEndostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cellsJ Pathol2010222324926020814900
   PubMed Web of Science ®Google Scholar
• SongHFLiuXWZhangHNPharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeysActa Pharmacol Sin200526112412815659125
   PubMed Web of Science ®Google Scholar
• JiangLPZouCYuanXN-terminal modification increases the stability of the recombinant human endostatin in vitroBiotechnol Appl Biochem200954211312019527221
   PubMed Web of Science ®Google Scholar
• CohenSYoshiokaTLucarelliMHwangLHLangerRControlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheresPharm Res1991867137202062800
   PubMed Web of Science ®Google Scholar
• RoyASinghMSUpadhyayPKBhaskarSCombined chemoimmunotherapy as a prospective strategy to combat cancer: A nanoparticle based approachMol Pharm2010 Sep 16 [Epub ahead of print]
   Web of Science ®Google Scholar
• MukherjeeBSantraKPattnaikGGhoshSPreparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymersInt J Nanomedicine20083448749619337417
   PubMed Web of Science ®Google Scholar
• GrefRQuellecPSanchezADevelopment and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriersEur J Pharm Biopharm200151211111811226817
   PubMed Web of Science ®Google Scholar
• ThomasJPArzoomanianRZAlbertiDPhase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumorsJ Clin Oncol200321222323112525513
   PubMed Web of Science ®Google Scholar
• TentlerJJBradshaw-PierceELSerkovaNJAssessment of the in vivo antitumor effects of ENMD-2076, a novel multitargeted kinase inhibitor, against primary and cell line-derived human colorectal cancer xenograft modelsClin Cancer Res201016112989299820406842
   PubMed Web of Science ®Google Scholar
• JieJZWangJWQuJGHungTSuppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse modelWorld J Gastroenterol200713131938194617461494
   PubMed Web of Science ®Google Scholar
• GaoJKnutsenAArbmanGClinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancerDig Liver Dis200941211612219038587
   PubMedGoogle Scholar
• WuJWuLXuXMicrospheres made by w/o/o emulsion method with reduced initial burst for long-term delivery of endostar, a novel recombinant human endostatinJ Pharm Sci20099862051205818823006
   PubMed Web of Science ®Google Scholar
• LiYPeiYZhangXPEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in ratsJ Control Release200171220321111274752
   PubMed Web of Science ®Google Scholar
• HobbsSKMonskyWLYuanFRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironmentProc Natl Acad Sci U S A1998958460746129539785
   PubMed Web of Science ®Google Scholar
• SonSLeeWRJoungYKOptimized stability retention of a monoclonal antibody in the PLGA nanoparticlesInt J Pharm20093681217818518955123
   PubMed Web of Science ®Google Scholar
• MandalDChatterjeeUSynthesis and spectroscopy of CdS nanoparticles in amphiphilic diblock copolymer micellesJ Chem Phys20071261313450717430047
   PubMed Web of Science ®Google Scholar
• ArimuraHOhyaYOuchiTFormation of core-shell type biodegradable polymeric micelles from amphiphilic poly(aspartic acid)-block-polylactide diblock copolymerBiomacromolecules20056272072515762635
   PubMed Web of Science ®Google Scholar
• WangMThanouMTargeting nanoparticles to cancerPharmacol Res2010622909920380880
   PubMed Web of Science ®Google Scholar
• LiSDHuangLNanoparticles evading the reticuloendothelial system: Role of the supported bilayerBiochim Biophys Acta20091788102259226619595666
   PubMed Web of Science ®Google Scholar
• JeongYIKangMKSunHSAll-trans-retinoic acid release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymerInt J Pharm2004273129510715010124
   PubMed Web of Science ®Google Scholar
• ZhangXPanSRHuHMPoly(ethylene glycol)-block-polyethylenimine copolymers as carriers for gene delivery: Effects of PEG molecular weight and PEGylation degreeJ Biomed Mater Res A200884379580417635020
   PubMed Web of Science ®Google Scholar
• MuthuMNanoparticles based on PLGA and its co-polymer: An overviewAsian J Pharm200934266273
   Google Scholar
• PeerDKarpJMHongSNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• WangMDShinDMSimonsJWNieSNanotechnology for targeted cancer therapyExpert Rev Anticancer Ther20077683383717555393
   PubMed Web of Science ®Google Scholar
• PetrosRAde SimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
   PubMed Web of Science ®Google Scholar
• KiskerOBeckerCMProxDContinuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor modelCancer Res200161207669767411606410
   PubMed Web of Science ®Google Scholar
• XuFMaQShaHOptimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatmentCrit Rev Ther Drug Carrier Syst200724544549218197781
   PubMed Web of Science ®Google Scholar
• LingYLuNGaoYEndostar induces apoptotic effects in HUVECs through activation of caspase-3 and decrease of Bcl-2Anticancer Res200929141141719331180
   PubMed Web of Science ®Google Scholar